Vanderbilt University Medical Center is receiving $3.3 million over two years through the Advanced Research Projects Agency for Health’s (ARPA-H) Sprint for Women’s Health for its early-stage research efforts to develop medications designed to suppress premature uterine contractions during pregnancy. 

Read More